Globe Life Inc. $GL Position Reduced by Aberdeen Group plc

Aberdeen Group plc lowered its position in shares of Globe Life Inc. (NYSE:GL) by 54.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,767 shares of the company’s stock after selling 5,616 shares during the quarter. Aberdeen Group plc’s holdings in Globe Life were worth $684,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Abich Financial Wealth Management LLC bought a new position in Globe Life in the 3rd quarter worth about $53,000. Public Sector Pension Investment Board raised its position in shares of Globe Life by 2.9% during the third quarter. Public Sector Pension Investment Board now owns 17,481 shares of the company’s stock worth $2,499,000 after purchasing an additional 485 shares during the period. Atria Investments Inc boosted its holdings in shares of Globe Life by 97.1% in the third quarter. Atria Investments Inc now owns 13,135 shares of the company’s stock worth $1,878,000 after buying an additional 6,470 shares during the period. Illinois Municipal Retirement Fund lifted its holdings in shares of Globe Life by 0.3% in the third quarter. Illinois Municipal Retirement Fund now owns 41,118 shares of the company’s stock valued at $5,879,000 after purchasing an additional 104 shares in the last quarter. Finally, LSV Asset Management grew its stake in Globe Life by 16.4% during the 3rd quarter. LSV Asset Management now owns 66,415 shares of the company’s stock valued at $9,495,000 after acquiring an additional 9,335 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on GL shares. Truist Financial upped their target price on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Weiss Ratings raised Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Keefe, Bruyette & Woods increased their price target on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. Evercore set a $157.00 target price on shares of Globe Life in a research report on Wednesday. Finally, TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus price target of $171.22.

Globe Life Stock Up 0.3%

Shares of GL stock opened at $144.41 on Monday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The firm’s fifty day moving average price is $141.43 and its two-hundred day moving average price is $138.57. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The firm has a market capitalization of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the business earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This trade represents a 25.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total value of $1,431,400.00. Following the transaction, the chief marketing officer directly owned 17,479 shares in the company, valued at $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 63,629 shares of company stock worth $9,223,785 in the last 90 days. 1.97% of the stock is currently owned by company insiders.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.